cyp

Documents about cyp

• Cyprus – Clothing, footwear, luggage articles and accessories – Διαγωνισμός για την προμήθεια 151 ζευγών Αρβύλων για τις ανάγκες της Υγειονομικής Υπηρεσίας — Υπουργείο Υγείας (CYP) · 13892 EUR#782644EU TED (Tenders Electronic Daily)
• Voxelotor CYP and Transporter Cocktail Interaction Study#123407ClinicalTrials.gov
• Cyprus – Chemical products – Προμήθεια και παράδοση Υποχλωριώδες Νατρίου για τις ανάγκες του ΕΟΑ Λάρνακας — ΕΠΑΡΧΙΑΚΟΣ ΟΡΓΑΝΙΣΜΟΣ ΑΥΤΟΔΙΟΙΚΗΣΗΣ ΛΑΡΝΑΚΑΣ (CYP) · 365000 EUR#1392488EU TED (Tenders Electronic Daily)
• Cyprus – Medical equipments – Διαγωνισμός για την αγορά/εγκατάσταση/συντήρηση έξι (6) επαγγελματικών εργαστηριακών ψυγείων φύλαξης εμβολίων και δεκαπέντε (15) φορητών ακουομέτρων προληπτικού ελέγχου α — Υπουργείο Υγείας (CYP) · 46587 EUR#1180282EU TED (Tenders Electronic Daily)
• Cyprus – Security, fire-fighting, police and defence equipment – Περιοδικό έλεγχο συντήρηση και αναγόμωση πυροσβεστήρων για τις διάφορες Κυβερνητικές Υπηρεσίες στη Λευκωσία — Τμήμα Δημοσίων Έργων (CYP) · 1226 EUR#1304530EU TED (Tenders Electronic Daily)
• Cyprus – IT services: consulting, software development, Internet and support – “Provision of Data Readiness Assessment Services” with tender procedure no. CyI/DiGiNN/DReAsS/2026 — THE CYPRUS INSTITUTE (CYP) · 30000 EUR#605784EU TED (Tenders Electronic Daily)
• Cyprus – Rechargers – Αρ. Διαγ. 026.024.Π.ΗΜΥ - Προμήθεια, Εγκατάσταση, Συντήρηση και Παραχώρηση Λειτουργίας Σταθμών Επαναφόρτισης Ηλεκτρικών Οχημάτων στον Σταθμό Λεωφορείων Αλάμπρας. — Τμήμα Ηλεκτρομηχανολογικών Υπηρεσιών (CYP) · 299500 EU#655923EU TED (Tenders Electronic Daily)
• Cyprus – Chemical products – 507/2026 - Supply of Caustic Soda 50 percent Solution for Reverse Osmosis Plant at Vasilikos Power Station — Electricity Authority of Cyprus (CYP) · 675000 EUR#1180518EU TED (Tenders Electronic Daily)
• Flucloxacillin as an Inducer of CYP-enzymes#121417ClinicalTrials.gov
• HepaRGTM CYP induction test method augmentation part 1: The GOLIATH Study#1235724HAL (France)
• Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects#1172716ClinicalTrials.gov
• Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy#826126ClinicalTrials.gov
• Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects#1115208ClinicalTrials.gov
• A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001#1349641ClinicalTrials.gov
• The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans#1114338ClinicalTrials.gov
• A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants#1321592ClinicalTrials.gov
• Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers#909990ClinicalTrials.gov
• A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib#1244768ClinicalTrials.gov
• Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics#1320272ClinicalTrials.gov
• Variance of Oral Methadone Dosage: Description of Implicated Factors#1125822ClinicalTrials.gov
• Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism#1279469ClinicalTrials.gov
• Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A#1295260ClinicalTrials.gov
• A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease#909814ClinicalTrials.gov
• Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects#918660ClinicalTrials.gov
• Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants#892988ClinicalTrials.gov
• Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants#162434ClinicalTrials.gov
• Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.#812961ClinicalTrials.gov
• Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients#1009326ClinicalTrials.gov
• Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability#1072027ClinicalTrials.gov
• Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition#1398199ClinicalTrials.gov
• Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole#898227ClinicalTrials.gov
• Determinación del tiempo de secado de granos de cacao (Theobroma cacao L.) peruano CYP-99, CEA-15 y CEA-21 para su comercialización#396948Repositorio Universidad Nacional Agraria La Molina
• The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity#904137ClinicalTrials.gov
• Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects#874394ClinicalTrials.gov
• Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms#981318ClinicalTrials.gov
• Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.#874182ClinicalTrials.gov
• A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants#893995ClinicalTrials.gov
• Integrative Profiling of Metabolic CYP Expression, DNA Mutation Rates, and Immune Cell Infiltration for Survival Prognosis in Hepatocellular Carcinoma / Mona Dawood, Axel Guthart, Ednah Ooko, Ralf Weiskirchen, Thomas Efferth, Joelle C. Boulos#628969Deutsche Nationalbibliothek
• Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years)#1044779ClinicalTrials.gov
• The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia#807373ClinicalTrials.gov
• Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol#1362463ClinicalTrials.gov